Buy, Sell or Hold: ConjuChem Inc (CJB-T) — Stock Predictions at Stockchase

skip to content

Home Daily Stock Opinions and Ratings ConjuChem Inc (CJB-T)

0.00

0.00 (0.00%) 1d

DON'T BUY

Thinks it’s a horrible company. Last year they did $120 million of financing at $0.65. The $1 stock immediately plunged to $0.65. Last week they announced a $20 million financing at $0.15 convertible debenture. Has gone through $120 million in 12 months.

biotechnology / pharmaceutical

DON'T BUY

Thinks it will bounce around a little bit. Not his favourite name. Continue to spend a lot of money and ultimately will have to come back to the market, perhaps some time next year. With the state of biotechs, both large and small, it is not a sector he would want to be in right now. Doesn't like the management.

biotechnology / pharmaceutical

WEAK BUY

Had a problem with nausea on their drug. Data is improving. Starting to fix the nausea problem. A very effective product. Did another financing, so they are well cashed up. Not the best management team.

biotechnology / pharmaceutical

WAIT

Was concerned when their drug was causing nausea, so they sold. Thinks they will have to do a lot of work. Will watch to see if they can solve the problem.

biotechnology / pharmaceutical

DON'T BUY

The nausea under the diabetes drug is fixable under certain conditions, but the question is can the do it. If they can fix, it's a very robust product and will have a very big market.

biotechnology / pharmaceutical

WAIT

Sold his holdings because of the convertible debenture issued. Too early to go back in. Expect their will be a lot of tax selling towards the end of the year and will look at it at that time.

biotechnology / pharmaceutical

DON'T BUY

The drop out rate on their diabetes drug was higher than expected. Wasn't happy the way management disseminated the information. Dead money in the near term.

biotechnology / pharmaceutical

WEAK BUY

Feels there is a potential drug here. Probably is near its bottom. A fair risk/reward. They are trying a new formulation re: nausea of the drugs they tested in phase 2 trials. Also waiting for a combination trial.

biotechnology / pharmaceutical

DON'T BUY

Needs to know more before he would buy. Have to see better results in the future. Buy when it's rising.

biotechnology / pharmaceutical

TOP PICK

Not really happy with management. Took a big drop and is an interesting buy now. The drug works. Potential of being in phase three next year. Really cheap.

biotechnology / pharmaceutical

DON'T BUY

Not sure you should buy it at this time. You want to hold it when there is a possibility of approval being given for their product.

biotechnology / pharmaceutical

DON'T BUY

A negative report on patient's reactions created a drop in the stock. Drugs in phase one or phase two trials can be very volatile. Prefers larger companies.

biotechnology / pharmaceutical

BUY

An announcement is coming out next week and he thinks the news will be good, but would like it to be great. Speculative. Good management and balance sheet.

biotechnology / pharmaceutical

BUY

Stock has come off since they announced the successful trials on their diabetes applications. There is some risk, but has potential.

biotechnology / pharmaceutical

DON'T BUY

Has had a huge move. Has moved too far, too fast. Solid programs. Expensive.

biotechnology / pharmaceutical

Showing 1 to 15 of 23 entries

«
‹
1
2
›
»

Next Page

ConjuChem Inc(CJB-T) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for ConjuChem Inc is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

ConjuChem Inc(CJB-T) Frequently Asked Questions

What is ConjuChem Inc stock symbol?

ConjuChem Inc is a OTC stock, trading under the symbol CJB-T on the (). It is usually referred to as or CJB-T

Is ConjuChem Inc a buy or a sell?

In the last year, there was no coverage of ConjuChem Inc published on Stockchase.

Is ConjuChem Inc a good investment or a top pick?

ConjuChem Inc was recommended as a Top Pick by on . Read the latest stock experts ratings for ConjuChem Inc.

Why is ConjuChem Inc stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is ConjuChem Inc worth watching?

In the last year 0 stock analysts on Stockchase covered ConjuChem Inc. The stock is worth watching.

What is ConjuChem Inc stock price?

On , ConjuChem Inc (CJB-T) stock closed at a price of $.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

© Stockchase Inc.